We know this is an unprecedented time for everyone and we especially recognize that this serious health crisis could bring new concerns and challenges. As we navigate the COVID-19 crisis, Novo Nordisk is focusing on three key priorities:
- Ensuring patients continue to get the medicines they need
- Keeping our employees safe
- Supporting the public health agenda
For general inquiries: 1.800.727.6500
For our Diabetes Patient Assistance Program, affordability and NovoCare services: 1.844.NOVO4ME (844.668.6463) or visit NovoCare.com
For Rare Bleeding Disorder services, please visit NovoSecure.com
If you’re a healthcare professional: NovoMedLink is your source for diabetes product samples and support during the Coronavirus outbreak. For growth hormone, please contact your local representative.